Código QR (código de barras bidimensional)

Alzheimer's disease drug development in an evolving therapeutic landscape

Abstract The Alzheimer's disease (AD) research field has entered a new era, where our fundamental understanding of the pathophysiology of AD and advances in biomarkers have not only allowed for earlier, timely, and accurate detection and diagnosis of the disease, but that amyloid removal has been sh...

ver descrição completa

Na minha lista:
Principais autores: Stacie Weninger, Michael C. Irizarry, Adam S. Fleisher, Teresa León, Paul Maruff, David S. Miller, Sheila Seleri, Maria C. Carrillo, Christopher J. Weber
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2024-10-01
coleção:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Assuntos:
Alzheimer's disease
amyloid beta‐protein
biomarkers
cognitive function
combination therapies
dementia
Acesso em linha:https://doi.org/10.1002/trc2.70015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados